missing translation for 'onlineSavingsMsg'
Learn More

Tosedostat, MedChemExpress

Product Code. 16488777
Encompass_Preferred
Click to view available options
Quantity:
5 mg
10 mg
25 mg
50 mg
100 mg
Unit Size:
100mg
10mg
25mg
50mg
5mg
This item is not returnable. View return policy

Product Code. 16488777

Brand: Medchem Express HY14807

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress Tosedostat (CHR-2797) is an orally active aminopeptidase inhibitor. CHR-2797 exerts antiproliferative effects against a range of tumor cell lines.

Tosedostat (CHR-2797) is an orally active aminopeptidase inhibitor. CHR-2797 exerts antiproliferative effects against a range of tumor cell lines.

Specifications

Chemical Name or Material Tosedostat
Physical Form Solid
CAS 238750-77-1
Color White
Quantity 5 mg
Purity Grade Notes Research
Molecular Formula C21H30N2O6
For Use With (Application) Cancer-programmed cell death
Synonym CHR-2797
Solubility Information DMSO : 25 mg/mL (61.51 mM; Need ultrasonic and warming)
SMILES O=C(OC1CCCC1)[C@@H](NC([C@@H]([C@H](O)C(NO)=O)CC(C)C)=O)C2=CC=CC=C2
Molecular Weight (g/mol) 406.47
Formula Weight 406.47
Percent Purity 98.37%
Grade Research
Show More Show Less

Research purposes only

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.